APPLICATION
ANDA212533
TYPE
ANDA
ORIGINAL APPROVAL
2021-11-10
LATEST ACTION
2023-12-05
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
LEVOCARNITINEPrescription
LEVOCARNITINE 1GM/10ML · SOLUTION · ORAL
Approval history
2023-12-05Manufacturing (CMC) · Supplement 3 · unknownAP
2021-11-10UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.